5-HT 2 -type serotonin receptors (5-HT 2 Rs) are widely expressed throughout the brain and mediate many of the modulatory effects of serotonin. It has been thought that postsynaptic 5-HT 2 Rs act primarily by depolarizing neurons and thereby increasing their excitability. However, it is also known that 5-HT 2 Rs are coupled to G q/11 -type G-proteins and that some other types of G q/11 -coupled receptors can regulate synapses by evoking endocannabinoid release and activating presynaptic cannabinoid-type 1 receptors (CB 1 Rs). Here, we examine whether activation of 5-HT 2 Rs can regulate synapses through such a mechanism by studying excitatory synapses onto cells in the inferior olive (IO). These cells express 5-HT 2 Rs on their soma and dendrites, and the IO receives extensive serotonergic input. We find that the excitatory synaptic inputs onto IO cells are strongly suppressed by serotonin receptor agonists as well as release of endogenous serotonin. Both 5-HT 2 Rs and 5-HT 1B Rs contribute to this modulation by decreasing the probability of glutamate release from presynaptic boutons. The suppression by 5-HT 2 Rs is of particular interest because it is prevented by CB 1 R antagonists, and 5-HT 2 Rs are thought to be located only postsynaptically on IO cells. Our results indicate that serotonin activates 5-HT 2 Rs on IO neurons, thereby releasing endocannabinoids that act retrogradely to suppress glutamate release by activating presynaptic CB 1 Rs. These findings establish a link between serotonin signaling and endocannabinoid signaling. Based on the extensive distribution of 5-HT 2 Rs and CB 1 Rs, it seems likely that this mechanism could mediate many of the actions of 5-HT 2 Rs throughout the brain.
Introduction
Activation of postsynaptic 5-HT 2 -type serotonin receptors (5-HT 2 Rs) is known to alter cell excitability by depolarizing cells (Barnes and Sharp, 1999; Leysen, 2004) . 5-HT 2 Rs are known to couple to G q/11 -type G-proteins (Barnes and Sharp, 1999; Hoyer et al., 2002; Leysen, 2004; Parrish and Nichols, 2006) , and activation of some other types of G q/11 -coupled receptors, such as metabotropic glutamate mGluR1/5 and muscarinic acetylcholine receptors, can promote endocannabinoid release from the dendrites of cells (Maejima et al., 2001; Varma et al., 2001; Kim et al., 2002; Chevaleyre et al., 2006; Oliet et al., 2007) . Endocannabinoids can cross the synaptic cleft and bind to presynaptic cannabinoid-type 1 receptors (CB 1 Rs), which reduce the probability of transmitter release (Chevaleyre et al., 2006) . Here we test the hypothesis that activation of 5-HT 2 Rs can also regulate synapses by promoting endocannabinoid release.
The inferior olive (IO) is well suited to testing this possibility. 5-HT 2A Rs are highly expressed on the dendrites and soma of neurons within the IO (Fay and Kubin, 2000; Fonseca et al., 2001) , and the IO receives a dense projection from serotonergic brainstem nuclei (Takeuchi and Sano, 1983; Bishop and Ho, 1986) . Binding studies indicate that cannabinoid receptors are present in the IO (Mailleux and Vanderhaeghen, 1992) , and phospholipase C␤4 (PLC␤4), which is known to be important for G q/11 -dependent endocannabinoid release, is expressed in the dendrites of IO cells (Nakamura et al., 2004) . Finally, it is possible to cut a slice containing the IO and brainstem nuclei that provide serotonergic inputs, raising the possibility of examining the effects of endogenous serotonin on synaptic transmission.
For many regions of the IO, such as the dorsal principal olive (dPO) studied here, the mesodiencephalic regions (MDRs) are the primary source of excitatory inputs. More specifically, the dPO receives excitatory inputs from MDRs such as the parvocellular red nucleus, the nucleus of Darkschewitsch, and the nucleus of the optic tract (Swenson and Castro, 1983a,b; Azizi and Woodward, 1987; de Zeeuw et al., 1990; De Zeeuw et al., 1998) . The properties and plasticity of these synapses have not been determined.
Here we examine excitatory synapses onto dPO cells in rat brain slices. We find that serotonin strongly suppresses EPSCs both by activating presynaptic 5-HT 1B Rs and by activating postsynaptic 5-HT 2 Rs. The activation of 5-HT 2 Rs evokes endocannabinoid release from dPO neurons, which binds to presynaptic CB 1 Rs to decrease the probability of release. Furthermore, we find that stimulation of serotonergic brainstem nuclei within our slices can release sufficient serotonin to activate 5-HT 2 Rs and result in endocannabinoid-mediated suppression of excitatory synapses onto dPO cells. These findings establish a link between serotonin and cannabinoid signaling systems.
Materials and Methods
Tissue preparation. Sprague Dawley rats were deeply anesthetized with ketamine/xylazine, placed in an ice bath, and transcardially perfused with an ice-cold sucrose solution consisting of the following (in mM): 82.7 NaCl, 23.8 NaHCO 3 , 71.2 sucrose, 23.7 glucose, 2.4 KCl, 1.4 NaH 2 PO 4 , 6.8 MgCl 2 , and 0.5 CaCl 2 . Brains were quickly removed and placed in ice-cold sucrose solution. The brainstem was isolated and placed on its dorsal surface on an agar block. The agar block was cut so that the brainstem would lean forward ϳ30°toward the blade when placed upright on the slicing pedestal. Sections, 250 m thick, containing the inferior olive were cut and transferred to the recording solution that consisted of the following (in mM): 125 NaCl, 26 NaHCO 3 , 25 glucose, 2.5 KCl, 1.25 NaH 2 PO 4 , 1 MgCl 2 , and 2 CaCl 2 . Slices were incubated for 45 min at 32°C and then allowed to cool to room temperature. All solutions were bubbled with 95% O 2 /5% CO 2 . Experiments were performed at 34 -35°C using an in-line heater (Warner Instruments). Recording solution flow rates were 3.5-4 ml/min. Postnatal day 10 (P10) to P15 rats were used for experiments. In older animals, active conductances precluded the accurate quantification of EPSCs. Based on electron microscopic examination of the medial accessory olive, it is likely that gap junctional coupling within the dPO first begins to appear at P10 and is relatively mature by P15 (Bourrat and Sotelo, 1983) . The active conductances we record along with EPSCs begin to develop during this period and become prominent by P15. We found that the active conductances do not result from gap junctional currents because they were not prevented by application of the gap junction blocker mefloquine. Preliminary experiments in older animals in which we observed active components associated with the EPSCs showed qualitatively similar results. All procedures involving animals were approved by the Harvard Medical Area Standing Committee on Animals.
Electrophysiology. Whole-cell voltage-clamp recordings were obtained from dPO neurons using a Multiclamp 700A (Molecular Devices). Recording pipettes had a resistance of 1.8 -3.4 M⍀ when filled with internal recording solution. Cells were held at Ϫ70 mV. The internal recording solution for voltage-clamp experiments consisted of the following (in mM): 145 Cs methane sulfonate, 15 HEPES, 0.2 EGTA, 1 MgCl 2 , 5 tetraethylammonium-Cl, 2 Mg-ATP, 0.3 Na-GTP, 10 phosphocreatine (tris), and 2 N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium (QX-314) (adjusted to ϳ315 mOsm, pH 7.3). In some experiments C 14 H 22 N 2 O was inadvertently used instead of QX-314. Data were similar in both conditions. The internal recording solution for current-clamp experiments consisted of the following (in mM): 114 K methane sulfonate, 6 NaCl, 10 HEPES, 0.5 EGTA, 2 MgSO 4 , 0.16 CaCl 2 , 4 Na-ATP, 0.4 Na-GTP, and 14 phosphocreatine (Tris) (adjusted to ϳ315 mOsm, pH 7.3). EPSCs were evoked in the presence of picrotoxin (50 M) to block GABA A Rs, CGP 55845 [(2S)-3-[(15)-1-(3,4-dichlorophenyl) ethyl]amino-2-hydroxypropyl)(phenylmethyl)-phosphinic acid] (2 M) to block GABA B Rs, and strychnine (1 M) to block glycine receptors. Experiments involving pressure-applied glutamate were done in the presence of TTX (500 nM) to block voltage-gated sodium channels, 6-amino-N-cyclohexyl-N,3-dimethylthiazolo [3,2-a] benzimidazole-2 carboxamide hydrochloride (YM 298198) (5 M) to block mGluR1 receptors, and 2-methyl-6-(phenylethynyl)-pyridine (MPEP) (5 M) to block mGluR5 receptors. Two of the four experiments involving pressure-applied glutamate were recorded in the presence of 3-((R)-2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (R-CPP) (5 M) to block NMDA receptors. For stimulation of serotonergic brainstem nuclei, stainless steel Tefloncoated bipolar electrodes (0.005 inch wire; A-M Systems) were placed as in Figure 5A . All experiments involving stimulation of endogenous serotonin release were done in the presence of YM 298198 (5 M) and MPEP (5 M) to prevent inadvertent activation of PLC through mGluR1 and mGluR5. Numerical values used in the text and in bar graphs were based on the average amplitudes of the first two test stimuli after the conditioning train.
Axons from the MDR do not form well defined fiber tracts as they enter the IO, and it is impractical to cut slices that include the IO and the MDR. Because IO projection neurons are not thought to give rise to excitatory local collaterals (Desclin and Colin, 1980; Foster and Peterson, 1986 ; De Zeeuw et al., 1998), we stimulated EPSCs by placing pairs of glass pipettes into the neuropil of the dPO. For experiments involving agonist application, pairs of EPSCs were evoked with an interstimulus interval of 20 ms at 0.1 Hz. Systematic increases in the stimulus intensity were accompanied by gradual increases in the size of the evoked EPSC, suggesting that individual synaptic currents were small. Stimulus strength was adjusted to activate EPSCs of Ͼ400 pA, which consisted of many synaptic inputs and provided a stable response. In experiments in which currents were evoked by pressure application of glutamate (1 mM, 20 ms pulses at 0.1 Hz), the pressure (10 -20 psi) was adjusted to evoke currents of Ͻ400 pA. Electrodes 2.5 m in tip diameter were placed ϳ10 m into the slice at a position 10 -40 m from the cell body. Only minor movements were observed. Vehicles were balanced across solutions during consecutive application of agonists followed by antagonists. Solution tubing was changed after application of N- (piperidin-1-yl Data acquisition and analysis. Recordings were filtered at 3 kHz and sampled at 20 kHz with a 16-bit analog-to-digital converter (ITC-18; InstruTech). All analysis was performed using custom macros written in Igor Pro (Wavemetrics). Statistical significance was determined with t tests and ANOVAs. Tukey's tests were used for post hoc analysis. Statistical significance was defined as p Ͻ 0.05. All data are expressed as means Ϯ SEM.
Results

EPSCs recorded from IO cells are suppressed by serotonin
Whole-cell recordings were obtained from neurons within the dPO region of the IO in brainstem slices ( Fig. 1 A, gray region). The dPO is readily identified within our transverse slice preparation using the white matter outlining each subnucleus as a reference. Although a few inhibitory interneurons are present within some IO subnuclei, they are not commonly found in the rat dPO, which consists almost exclusively of large excitatory projection neurons that give rise to the climbing fibers that innervate Purkinje cells (Fredette et al., 1992; De Zeeuw et al., 1998) . Recordings from these neurons within the dPO exhibited properties stereotypical of IO projection neurons. Each action potential was associated with a high-threshold calcium spike (Fig. 1C, arrow) when the initial membrane potential was near Ϫ55 mV (Llinas and Yarom, 1981a,b) and robust subthreshold oscillations were apparent (Fig. 1 D) . Thus, our recordings are from IO projection neurons within the dPO.
Anatomical studies suggest that the dPO receives excitatory synapses from the MDR (Fig. 1 B) . Synaptic inputs were stimulated with an electrode placed in the neuropil of the dPO (Fig.  1 A) . The EPSCs we recorded from dPO cells had consistent properties. EPSCs were recorded from dPO cells by stimulating in the presence of blockers of inhibitory neurotransmission and could be blocked by the AMPA receptor antagonist NBQX (5 M) and the NMDA receptor antagonist R-CPP (5 M) (data not shown).
Neuromodulatory fibers from serotonergic brainstem nuclei also provide a powerful input to the IO ( Fig. 1 B) (Takeuchi and Sano, 1983; Bishop and Ho, 1986) . Previous studies have shown that serotonin can depolarize neurons within the IO (Placantonakis et al., 2000), but it was not known whether serotonin regulates synaptic inputs to these cells. We found that bath application of 5-HT (10 M) suppressed EPSCs recorded from dPO cells to 14 Ϯ 3% (n ϭ 5 cells) of control (Fig. 1 E) .
IO cells are known to strongly express 5-HT 2A Rs, which are coupled to the G-protein G q/11 (Fay and Kubin, 2000; Fonseca et al., 2001 ). We therefore tested whether 5-HT 2 Rs were involved in the suppression of excitatory synapses. Because selective 5-HT 2A R agonists are not available (Leysen, 2004) , we attempted to attain selective activation of 5-HT 2A Rs by using a low concentration of the high-affinity synthetic 5-HT 2A R agonist TCB-2. Although TCB-2 is reported to activate 5-HT 2A Rs, it is not known how selective this compound is for 5-HT 2A Rs. TCB-2 (1 M) mimicked the effect of serotonin and reduced EPSCs to 15 Ϯ 1% (n ϭ 12 cells) of control (Fig. 2 A-C) . The effect of TCB-2 on EPSCs was only partially reversed by the 5-HT 2 R antagonist ritanserin (4 M) (43 Ϯ 6% of baseline; n ϭ 4 cells) (Fig. 2 A) . This indicated that the suppression of EPSCs by TCB-2 involves another 5-HTR in addition to 5-HT 2 Rs. Previous studies at other synapses have found that activation of presynaptic 5-HT 1B Rs can suppress release from presynaptic boutons (Sari, 2004; Seeburg et al., 2004) . We examined the role of 5-HT 1B Rs in modulating EPSCs onto dPO neurons by applying TCB-2, followed by coapplying TCB-2 and the 5-HT 1B R antagonist NAS-181 (1 M). NAS-181 also partially reversed the effect of TCB-2 on EPSCs (34 Ϯ 3% of baseline; n ϭ 4 cells) (Fig. 2 B) . Despite the partial recovery of TCB-2-mediated suppression by ritanserin or NAS-181 alone, coapplication of ritanserin and NAS-181 completely reversed the effect of TCB-2 (105 Ϯ 13% of baseline; n ϭ 4 cells) (Fig. 2C) . Moreover, in the presence of NAS-181, the effect of TCB-2 was completely reversed by ritanserin (108 Ϯ 3% of baseline; n ϭ 4 cells) (Fig. 2 D) . These findings indicate that activation of 5-HT 2 Rs and 5-HT 1B Rs accounts for the EPSC suppression by TCB-2.
We determined whether activation of 5-HT 2 Rs and 5-HT 1B Rs modulates transmission through a presynaptic mechanism by measuring the paired-pulse ratio. Activation of 5-HT 2 Rs by applying TCB-2 in the presence of NAS-181 increased the pairedpulse ratio (1.43 Ϯ 0.19 to 2.00 Ϯ 0.22; n ϭ 6 cells; paired t test, p Ͻ 0.05) (Fig. 3A) . This suggests that 5-HT 2 R activation suppresses EPSCs through a presynaptic mechanism, despite the observation that 5-HT 2A Rs are prominently expressed postsynaptically on IO cells (Fay and Kubin, 2000; Fonseca et al., 2001 ). Activation of 5-HT 1B Rs by applying TCB-2 in the presence of ritanserin increased the paired-pulse ratio (1.42 Ϯ 0.13 to 2.11 Ϯ 0.15; n ϭ 5 cells; paired t test, p Ͻ 0.05) (Fig. 3B ). This suggests that 5-HT 1B R activation suppresses EPSCs through a presynaptic mechanism.
We assessed whether activation of 5-HT 2 Rs and 5-HT 1B Rs alters the response of postsynaptic glutamate receptors. Miniature EPSCs were found to be poorly suited to detect decreases in glutamate receptor sensitivity because they are small and difficult to discriminate from the noise. We therefore examined the response to pressure-applied glutamate in the presence of TTX as well as antagonists of mGluR1 and mGluR5 (Fig. 3C,D) . Bath application of TCB-2, which activates both 5-HT 2 Rs and 5-HT 1B Rs, did not alter glutamate-evoked currents (98 Ϯ 5% of control; n ϭ 4 cells) (Fig. 3D) . This suggests that alterations in postsynaptic receptor sensitivity are unlikely to contribute to synaptic suppression after 5-HT 2 R and 5-HT 1B R activation.
5-HT 2 R activation suppresses EPSCs through endocannabinoid release
We next examined the mechanism of the presynaptic suppression of transmitter release produced by 5-HT 2 R activation. We tested the hypothesis that activation of postsynaptic 5-HT 2 Rs evokes endocannabinoid release from IO neurons that acts retrogradely to inhibit transmission through a presynaptic mechanism. We therefore determined whether CB 1 Rs are present on the presynaptic boutons of excitatory inputs. Bath application of the CB 1 R agonist WIN (2 M) strongly attenuated EPSCs (8 Ϯ 1% of control), and this suppression was reversed by the CB 1 R antagonist AM251 (111 Ϯ 22% of control; n ϭ 5 cells; 4 M) (Fig. 4 A) . WIN also increased the paired-pulse ratio (1.47 Ϯ 0.07 to 1.86 Ϯ 0.07; n ϭ 5 cells; one-factor ANOVA, p Ͻ 0.01), and AM251 reversed this effect (1.86 Ϯ 0.07 to 1.42 Ϯ 0.05) (Fig. 4 B) . This suggests that activation of CB 1 Rs located on presynaptic excitatory terminals can suppress the release of glutamate onto dPO cells.
Depolarization of some types of neurons evokes endocannabinoid release and leads to suppression of afferent synapses containing CB 1 Rs (Chevaleyre et al., 2006) . We assessed whether dPO cells can release endocannabinoids by depolarizing dPO cells for 3 s. This suppressed EPSCs for many seconds, and the CB 1 R antagonist AM251 (2 M) prevented this suppression (n ϭ 5 cells) (Fig. 4C) . Thus, dPO cells can release endocannabinoids from their dendrites and control the strength of their excitatory synapses.
We then tested whether CB 1 Rs mediate the suppression by 5-HT 2 Rs. The suppression of EPSCs by activation of 5-HT 2 Rs was prevented by including AM251 (2 M) in the bath (91 Ϯ 3% of control; n ϭ 4 cells) (Fig. 4 D) . This suggests that activation of postsynaptic 5-HT 2 Rs suppresses the release of neurotransmitter and requires the activation of CB 1 Rs.
We also found that the prominent gap junctions between cells in the IO are not required for the suppression. The gap junction blocker mefloquine (25 M for Ͼ1 h presoak) did not prevent the suppression mediated by 5-HT 2 Rs. Although mefloquine slightly reduced the extent of the suppression (45 Ϯ 5% of baseline; n ϭ 4 cells) (Fig. 4 E) compared with control (20 Ϯ 4%of baseline; n ϭ 4 cells), this reduction in the extent of suppression might reflect the numerous nonspecific effects of mefloquine (Coker et al., 2000; Gribble et al., 2000; Kang et al., 2001; Cruikshank et al., 2004; Caridha et al., 2008) .
Together, these findings suggest that activation of 5-HT 2 Rs evokes endocannabinoid release from IO cells, which acts on presynaptic CB 1 receptors to reduce the probability of neurotransmitter release.
Stimulation of serotonergic brainstem nuclei
The IO receives a dense projection of serotonergic axons from brainstem nuclei, including the nucleus reticularis paragigantocellularis, which is located in close proximity to the IO (Bishop and Ho, 1986) and is contained within our brain slices. We tested whether stimulation of neurons within serotonergic brainstem nuclei is sufficient to activate serotonin receptors on IO cells within our slice preparation (Fig. 5A) .
The in vivo firing properties of serotonergic neurons in the nucleus reticularis paragigantocellularis are not known. We therefore activated serotonergic brainstem nuclei with a stimulus train (50 stimuli at 50 Hz) to evoke large reproducible effects that were amenable to pharmacological analysis. In these experiments, excitatory inputs were activated with test stimuli at 0.5 Hz (Fig. 5B) . Activation of serotonergic inputs had two effects: it induced an inward current in IO cells (Fig. 5) , and it suppressed EPSCs (Fig. 6) .
The slow postsynaptic current (PSC) produced by activation of serotonergic brainstem nuclei was 100 Ϯ 14 pA (n ϭ 16 cells) and persisted for ϳ10 s. Previous studies have shown that 5-HT 2 R agonists depolarize IO cells (Placantonakis et al., 2000) , which corresponds to an inward current in voltage clamp. We therefore tested whether the slow PSC is mediated by 5-HT 2 Rs. Trains were delivered to serotonergic brainstem nuclei every 3 min, and this was repeated for eight trials. The slow PSCs recorded in response to the second and fifth trains were compared (Fig. 5C-F ) . The magnitude of the slow PSC diminished slightly over time within control conditions (69 Ϯ 4% of early response; n ϭ 4 cells) (Fig. 5C,D) . Bath application of ritanserin immediately after the second train virtually eliminated the slow PSC (16 Ϯ 8% of control; n ϭ 8 cells) (Fig. 5C,E) , and the reduction was significant relative to control (one-factor ANOVA, p Ͻ 0.01). This indicates that activation of serotonergic brainstem nuclei releases serotonin that activates 5-HT 2 Rs on IO cells. The bath application of AM251 had no effect on the magnitude of the inward current relative to control (81 Ϯ 9% of control; n ϭ 4 cells; one-factor ANOVA, NS) (Fig. 5C,F) , indicating that AM251 does not prevent the activation of 5-HT 2 Rs by serotonin.
In these experiments, we also tested whether release of endogenous serotonin suppresses EPSCs onto IO cells. Stimulation of serotonergic brainstem nuclei (50 stimuli at 50 Hz) suppressed EPSCs for ϳ15 s (40 Ϯ 2% of control; n ϭ 16 cells) (Fig. 6 A-E) . The average suppression in response to the first two trains was compared with the average suppression of the last three trains (Fig. 5B-G) . Trials were repeated every 3 min to prevent rundown, which was small in control conditions (suppression late was 82 Ϯ 4% of suppression early; n ϭ 4 cells) (Fig. 6 B, G) . Blockade of 5-HT 2 Rs with ritanserin alone did not significantly affect the magnitude of the suppression (80 Ϯ 5% of control suppression; n ϭ 4 cells; one-factor ANOVA, NS) (Fig. 6C,G) . Blockade of 5-HT 1B Rs with NAS-181 appeared to slightly decrease the magnitude of the initial suppression (Fig. 6 D) , but this was not significant (68 Ϯ 4% of control suppression; n ϭ 4 cells; one-factor ANOVA, NS) (Fig. 6G) . Coapplication of NAS-181 and ritanserin significantly reduced the magnitude of the suppression (26 Ϯ 9% of control suppression; n ϭ 4 cells; one-factor ANOVA, p Ͻ 0.01) (Fig. 6E,G) . This suggests that the suppression of EPSCs after stimulation of endogenous serotonin release results from activation of both 5-HT 2 Rs and 5-HT 1B Rs (Fig. 6C-E) , as was the case for bath application of 5-HTR agonists (Fig. 2) . Furthermore, activation of either 5-HT 2 Rs or 5-HT 1B Rs is sufficient to cause suppression of this synapse in a manner similar to that for bath application of 5-HTR agonists. Likewise, in the presence of NAS-181 to block 5-HT 1B Rs, application of AM251 to block CB 1 Rs significantly reduced the magnitude of the suppression (19 Ϯ 15% of control suppression; n ϭ 4 cells; one-factor Figure 5 . Stimulation of serotonergic brainstem nuclei produces a slow postsynaptic current in IO cells. A, A schematic illustrates the experimental configuration used to assess the effects of activation of serotonergic brainstem nuclei that project to the IO. Electrode S1 was used to stimulate excitatory inputs, and electrode S2 was used to activate serotonergic fibers. B, Raw trace (gray) illustrates the response to stimulation of EPSCs at 0.5 Hz with S1 and stimulation of serotonergic brainstem nuclei with S2 (bar, 50 stimuli at 50 Hz), which produced a slow PSC. The slow PSC could be studied in isolation by removing the stimulus artifacts and low-pass filtering at 1 Hz (black trace). C, Bar graph summarizes the amplitude of the slow PSC measured in trials separated by 9 min, with the first trial in control conditions and the second trial, in either control conditions (n ϭ 4 cells) or the presence of either ritanserin (n ϭ 8 cells) or AM251 (n ϭ 4 cells). D, Example slow PSCs recorded in early (black) and late (gray) control conditions. E, Example slow PSCs recorded before (black) and after (gray) the blockade of 5-HT 2 Rs with ritanserin. F, Example slow PSCs recorded in the presence of NAS-181 before (black) and after (gray) application of AM251. Data are means Ϯ SEM.
ANOVA, p Ͻ 0.01) (Fig. 6F,G) . This suggests that endogenously released serotonin suppresses EPSCs onto IO cells by activating both 5-HT 2 Rs and 5-HT 1B Rs. Moreover, the suppression resulting from 5-HT 2 R activation is mediated by CB 1 Rs.
The extent of suppression after activation of serotonergic inputs is less than the maximal suppression observed during bath application of either 10 M serotonin or the artificial agonist TCB-2. Bath application of 500 nM of exogenous serotonin resulted in a suppression of this synapse to 58 Ϯ 4% of control (n ϭ 4 cells), which is slightly less suppression than that observed after stimulation of serotonin release in the slice (40 Ϯ 2% of control; n ϭ 16 cells). This suggests that the concentration of serotonin accumulating in the slice after stimulation of serotonergic brainstem nuclei is likely slightly Ͼ500 nM, although factors such as receptor desensitization could complicate a comparison of the effects of prolonged bath application with transient serotonin signals generated by synaptic activation.
Discussion
We found that serotonin can activate postsynaptic 5-HT 2 Rs and evoke endocannabinoid release that acts retrogradely on the presynaptic terminal to reduce the probability of glutamate release. This finding links the serotonin and cannabinoid signaling systems and may be an important mechanism of serotonin modulation in the inferior olive and in other brain regions.
Serotonin in the IO
We have shown that serotonin can almost eliminate excitatory synaptic transmission onto dPO neurons. 5-HT 2 Rs and 5-HT 1B Rs are both involved in reducing the probability of release from the presynaptic terminals. In response to bath application of a serotonin receptor agonist, antagonists of either 5-HT 2 Rs or 5-HT 1B Rs alone only partially relieve the suppression. These findings indicate that activation of either type of receptor is sufficient to reduce synaptic transmission to Ͻ45% of control. The important role of both receptors was also apparent in experiments in which modulation was produced by activating serotonergic inputs to the dPO. One of the interesting aspects of the modulation observed under these conditions is that the blockade of either receptor alone has so little effect on the extent of modulation. Blockade of 5-HT 1B Rs may have slightly decreased the extent of inhibition immediately after the conditioning train, but the effect was small and suppression at later times was unaffected. One complicating factor is the apparent role of 5-HT autoreceptors in control of transmitter release from some serotonergic terminals (Sari, 2004; Sharp et al., 2007) . As a result, a 5-HTR antagonist could potentially increase the release of serotonin in addition to influencing excitatory synapses directly. Regardless of the potential for regulation of serotonin release, it is clear that 5-HT 2 Rs and 5-HT 1B Rs can both independently regulate excitatory synapses when serotonin is liberated by synaptic stimulation. This is the first demonstration that serotonin can regulate synapses in a retrograde manner by activating 5-HT 2 Rs to evoke endocannabinoid release. The modulation by 5-HT 2 Rs was studied in isolation by blocking 5-HT 1B Rs.
5-HT 2 R effects in the IO likely primarily result from activation of 5-HT 2A Rs because these receptors are expressed at high levels on the soma and dendrites of IO cells, whereas the other two 5-HT 2 R subtypes, 5-HT 2B and 5-HT 2C , are not thought to be present (Fay and Kubin, 2000; Fonseca et al., 2001; Leysen, 2004) . Despite the postsynaptic location of 5-HT 2A Rs, the suppression arising from activation of these receptors is expressed presynaptically. This suggests that a retrograde messenger is involved. For both exogenous serotonin receptor agonists and synaptically evoked serotonin release, suppression resulting from activation of 5-HT 2 Rs requires endocannabinoid activation of CB 1 Rs. This suggests that the retrograde messenger is an endocannabinoid, and depolarization-induced suppression of excitation experiments establish that IO cells can release endocannabinoids.
Synaptic modulation in the IO
The observation that serotonin suppresses excitatory synapses onto IO cells may help to explain previous results from in vivo experiments related to motor learning and motor activity. Previously, it was shown that injection of serotonin into the IO increased the synchrony of complex spikes recorded from Purkinje cells (Sugihara et al., 1995) . As serotonergic brainstem neurons increase their firing during repetitive movements (Jacobs and Fornal, 1997) , serotonin may promote synchronous activation of IO cells during repetitive motor activity by depolarizing IO cells Figure 5A . A, A representative experiment shows EPSC amplitudes as a function of time (left) recorded before and after stimulation at t ϭ 0 of brainstem serotonergic nuclei. EPSCs recorded at the indicated times are displayed (right). In B-F, experiments were conducted in which eight trials such as these were repeated at 3 min intervals, and the amplitudes of EPSCs for the first two trials (open circles) and last three trials (filled circles) were compared. In B, the entire experiment was performed in control conditions. In C-F, drugs were bath applied after the second trial and remained present for the duration of the experiment. The antagonists applied were the 5-HT 2 R antagonist ritanserin (C), the 5-HT 1B R antagonist NAS-181 (D), ritanserin and NAS-181 (E), and the CB 1 R antagonist AM251 (F ). G, The extent of the suppression for B-F is summarized by dividing the suppression observed in the last three trains by the suppression observed in the first two trains for each condition (n ϭ 4 cells for each condition; data are means Ϯ SEM).
and suppressing excitatory synaptic input. In addition, serotonin has been implicated in modulation of motor activity. For instance, systemically altering serotonin levels alters motor output (Jacobs and Fornal, 1997) . Our findings suggest that suppression of excitatory synapses within the IO is likely to contribute to the regulation of motor activity by serotonin.
Our findings also provide the first evidence that IO cells can release endocannabinoids and suppress their excitatory synaptic inputs by activating presynaptic CB 1 Rs. CB 1 R knock-out mice have deficits in delay eye-blink conditioning, which is a form of learning known to rely on cerebellar circuits (Kishimoto and Kano, 2006) . One possible explanation is that endocannabinoids are required for long-term depression in the cerebellar cortex (Safo et al., 2006) . However, climbing fibers convey the activity from the IO to the cerebellar cortex and play a crucial role in cerebellar learning (Raymond et al., 1996; Thompson, 2005) . Therefore, it is possible that alterations in CB 1 R signaling in the IO could contribute to deficits in delay eye-blink conditioning.
Implications for 5-HT 2 R signaling in other brain regions
The demonstration that, within the IO, activation of 5-HT 2 Rs acts in part by promoting the release of endocannabinoids has important implications for understanding how 5-HT 2 Rs could function in other brain regions. Studies in humans and animal models suggest that alterations in central serotonin levels affect depression and anxiety-related behaviors. One of the more likely targets for this modulation is 5-HT 2 Rs (Van Oekelen et al., 2003; Weisstaub et al., 2006) . 5-HT 2 Rs are also thought to play an important role in schizophrenia, epilepsy, and sleep (Van Oekelen et al., 2003; Leysen, 2004; Weisstaub et al., 2006) . 5-HT 2A Rs and the closely related 5-HT 2C Rs are highly expressed throughout the brain (Leysen, 2004) . Activation of cortical 5-HT 2 Rs is thought to mediate many of the hallucinogenic and mood-altering effects of drugs such as LSD (lysergic acid diethylamide) (Aghajanian and Marek, 1999; Gonzalez-Maeso et al., 2007) . Cortical 5-HT 2 Rs are also thought to play an important role in some psychiatric disorders because a number of antidepressant and antipsychotic drugs target these receptors (Gray and Roth, 2001; Leysen, 2004) . For instance, blockade of 5-HT 2 Rs is thought to enhance the therapeutic actions of selective serotonin reuptake inhibitors on depression (Marek et al., 2003; Celada et al., 2004) .
Likewise, CB 1 Rs are expressed widely and at a very high density throughout the CNS (Tsou et al., 1998; Freund et al., 2003; Chevaleyre et al., 2006) . Activation of cannabinoid receptors with exogenous agonists including THC (tetrahydrocannabinol), the active ingredient in marijuana, affects both mood and perception (Chevaleyre et al., 2006) . Furthermore, many areas contain both 5-HT 2 Rs and CB 1 Rs, including the neocortex, portions of the olfactory system, hippocampus, amygdala, and brainstem nuclei (Tsou et al., 1998; Barnes and Sharp, 1999; Hoyer et al., 2002; Freund et al., 2003; Leysen, 2004; Chevaleyre et al., 2006) . Our findings suggest that serotonin could act in part by promoting the release of endocannabinoids, thereby leading to suppression of synapses. More generally, our findings suggest a link between signaling by 5-HT 2 Rs and CB 1 Rs.
